{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:30:35Z","timestamp":1761708635248},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Recurrent aphthous stomatitis (RAS) is an autoimmune disorder characterized by the periodic appearance of aphthous lesions on the oral mucosa. TH1 cytokines plays a key role in the aetiopathogenesis. Autoimmune thyroid disease (ATD) is the most common autoimmune disease and is frequently accompanied by various other autoimmune diseases.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To investigate the frequency of ATD which has not been studied in the patients with RAS.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Ninety patients and 30 healthy volunteers were included into the study. The serum samples were assayed for thyroid stimulant hormone (TSH), free and total triiodothyronine (fT3, TT3), free and total thyroxine (fT4, TT4), thyroglobuline, anti\u2010thyroid peroxidase antibody (anti\u2010TPO) and anti\u2010thyroglobuline antibody (anti\u2010TG) levels. Thyroid ultrasonography was performed as well.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In RAS patients, the fT3, TT3 levels were higher; whereas the fT4 levels were lower that the control group (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05). The anti\u2010thyroid antibody was positive in 31.11% of the patients with RAS, and in only 10% of the individuals in the control group (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05). The mean anti\u2010TG level was also higher in the RAS group. Ultrasonography revealed nodules in 28.8% of the patients with RAS and in 16.7% of the individuals in the control group (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05). The sT4 levels were lower and the TSH, anti\u2010TPO and anti\u2010TG levels were significantly higher in the RAS patients with thyroid nodules than the RAS patients without nodules (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Discussion\u2002<\/jats:bold> These results may be related to either the advance age of the patients or the increased duration of the autoimmune activation which may affect the thyroid.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The frequency of thyroid autoimmune\u2010related problems was higher in patients with RAS. It would be worthy of searching autoimmune thyroid disorders in patients with RAS.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04040.x","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T05:33:34Z","timestamp":1301031214000},"page":"226-230","source":"Crossref","is-referenced-by-count":11,"title":["Thyroid autoimmunity associated with recurrent aphthous stomatitis"],"prefix":"10.1111","volume":"26","author":[{"given":"I.Y.","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Calka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8019.2002.01528.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.2008.00801.x"},{"key":"e_1_2_5_4_2","first-page":"157","article-title":"Recurrent aphthous stomatitis: etiology, diagnosis, and treatment","volume":"50","author":"Casiglia JM","year":"2002","journal-title":"Gen Dent"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.212.101"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600905380"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1214415"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1684\/ejd.2009.0632","article-title":"Autoimmune thyroid disorders in patients with psoriasis","volume":"19","author":"G\u00fcl \u00dc","year":"2009","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.01.002"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(99)00156-X"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02324.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-112-1-308"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(95)00095-X"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000148250"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.61.1.70","article-title":"Autoimmune thyroid disease in systemic lupus erythematosus","volume":"61","author":"Pyne D","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80223-X"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0263-8"},{"key":"e_1_2_5_18_2","first-page":"207","article-title":"The thyroid and autoimmunity","volume":"47","author":"Lichiardopol C","year":"2009","journal-title":"Rom J Intern Med"},{"key":"e_1_2_5_19_2","first-page":"775","volume-title":"Endokrinoloji, Temel ve Klinik","author":"Kolo\u011flu S","year":"2005"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2005.017"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0205"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.136"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0287"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"e_1_2_5_26_2","article-title":"Management of a solitary thyroid nodule","volume":"328","author":"Mazzaferri EL","year":"1993","journal-title":"N Engl J Med"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(69)90042-3"},{"key":"e_1_2_5_28_2","first-page":"817","article-title":"Prevention of stomatitis in patients with acute myelogenous leukemia using PVP\u2010iodine (Isodine) gargle","volume":"19","author":"Tsuzura Y","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_5_29_2","first-page":"264","article-title":"Autoimmune tyroidit with chronic idiopathic urticaria","volume":"38","author":"Cebeci F","year":"2004","journal-title":"Turkderm"},{"key":"e_1_2_5_30_2","first-page":"269","article-title":"Role of thyroid hormones in vitiligo type and progression","volume":"37","author":"Ar\u0131can \u00d6","year":"2003","journal-title":"Turkderm"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.01971.x"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01931.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00510.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03172.x"},{"key":"e_1_2_5_35_2","first-page":"319","article-title":"Recurrent aphtous stomatitis","volume":"26","author":"K\u00f6yba\u015f\u0131 S","year":"2006","journal-title":"T Klin J Med Sci"},{"key":"e_1_2_5_36_2","first-page":"405","article-title":"Thyroid functions in Behcet\u2019s disease","volume":"50","author":"Aksu K","year":"1999","journal-title":"Clin Endocrinol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:58:17Z","timestamp":1697385497000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04040.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04040.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}